October 01, 2023
Africa: U.S. Drug Company Eases Access to Multidrug-Resistant Tuberculosis Treatment
Company continues to be focused on addressing perceived barriers to access and refocusing global efforts on the most-pressing barrier to access: underdiagnosis of the disease. Read more »
March 31, 2020
Africa: Johnson & Johnson Announces Lead COVID-19 Vaccine Candidate, Will Supply 1 Billion Worldwide
Johnson & Johnson (NYSE: JNJ) (the Company) today announced the selection of a lead COVID-19 vaccine candidate from constructs it has been working on since January 2020; the… Read more »
Johnson and Johnson (New Brunswick)
Website: https://www.jnj.com/
